The National Rosacea Society is grateful to have been bequeathed significant support in recent years from members who have named it among charitable organizations listed as beneficiaries in their wills.

“We are honored to have received ongoing support from so many loyal individuals over the decades,” said Andrew Huff, president and executive director of the NRS. “Where possible, we hope they might consider making a final donation in their wills to help others who suffer from this chronic disorder in the years ahead.”

As a 501(c)(3) nonprofit organization, the NRS began accepting tax-deductible donations from individuals with the creation of its research grants program. Since 2000, it has awarded more than $1.6 million to fund 75 rosacea studies to expand scientific knowledge of the disorder that may lead to advances in its treatment, prevention and potential cure. Among a wide range of important results to date, these have included landmark discoveries in the roles of the autoimmune system and vascular dysregulation in the development of this widespread condition affecting more than 16 million Americans.